Teesside serves as test bed for “groundbreaking” dialysis patient technology

A technology will be evaluated across the Tees Valley that will enable patients on dialysis at home to have their treatment monitored remotely.

The technology is put into practice through the South Tees Hospital NHS Foundation Trust and partners at Teesside University, What Works Center for Wellbeing, and Alio Medical, a medical device company based in San Francisco, California.

The technology aims to enable patients and their caregivers to monitor critical treatment measurements at home without the need for invasive blood tests or hospital visits.

The project was funded by Q Lab UK, a collaboration between the Health Foundation and NHSX, which aims to build trust and confidence in technology-enabled remote monitoring to support digital skills development in the National Health Service.

Dr. Jonathan Murray, one of the kidney advisors at the South Tees Hospitals NHS Foundation Trust, has previously conducted similar reviews of Alio Medical technology on patients receiving dialysis in the hospital.

Dr. Murray said, “Our goal has always been to help develop technology that will allow patients to monitor their health remotely, including at home. This would empower patients and provide autonomy by effectively allowing patients to monitor their health and treatment as part of their daily activities, rather than the other way around.

“As we develop the Alio monitoring system, it is important for us to understand what factors are important to patients and would affect their use of this technology at home, and this project with Q Lab UK will help us achieve that.”

John S. Young is Professor of Translational Health Care at Teesside University’s National Horizons Center and will lead the project. Professor Young said, “This project has the potential to transform patients’ lives massively.

“The bottom line is that this is an implementation project rather than an attempt. Alio Medical hopes the technology will be approved for clinical use in the near future, and the current project will help support the later integration of this technology into treatment pathways.

“At Teesside University’s National Horizons Center, we work with healthcare providers and the bio-producing industry to innovate, test, and then deliver to the NHS – to deliver the patient benefit that unites all of our efforts.”

Dave Karaguntla, Alio CEO, commented, “We are excited to be working with South Tees and the NHS. Your tremendous support and collaboration gives Alio the opportunity to evaluate our dialysis patient monitoring system and how it will give a significant number of dialysis patients in their care more control over their own health. “

Would you like to advertise your product / service to SMEs in your region?

Find out how Bdaily can help →

Leave a Comment